Predicting risk of major adverse cardiac events

Invention Grant

US09886553B2 Predicting risk of major adverse cardiac events 有权

Please log in to see more content

Patent Title: Predicting risk of major adverse cardiac events
Application No.: US13787137

Application Date: 2013-03-06
Publication No.: US09886553B2

Publication Date: 2018-02-06
Inventor: James V. Snider , Eugene R. Heyman
Applicant: Critical Care Diagnostics, Inc.
Applicant Address: US CA San Diego
Assignee: Critical Care Diagnostics, Inc.
Current Assignee: Critical Care Diagnostics, Inc.
Current Assignee Address: US CA San Diego
Agency: Fish & Richardson P.C.
Main IPC: G06F19/00
IPC: G06F19/00 ; C12Q1/68 ; G01N33/68 ; G01N33/74

Predicting risk of major adverse cardiac events

Abstract:

Measurement of circulating ST2 and natriuretic peptide (e.g., NT-proBNP) concentrations is useful for the prognostic evaluation of subjects, in particular for the prediction of adverse clinical outcomes, e.g., mortality, transplantation, and heart failure.

Public/Granted literature

US20130244236A1 PREDICTING RISK OF MAJOR ADVERSE CARDIAC EVENTS Public/Granted day:2013-09-19

Information query

Espacenet